BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 15347726)

  • 61. Combined RNA interference of adenine nucleotide translocase-2 and ganciclovir therapy in hepatocellular carcinoma.
    Kim JE; Hwang MH; Lee HW; Lee SW; Lee J; Ahn BC
    Nucl Med Biol; 2013 Nov; 40(8):987-93. PubMed ID: 24054501
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Imaging of human sodium-iodide symporter gene expression mediated by recombinant adenovirus in skeletal muscle of living rats.
    Yang HS; Lee H; Kim SJ; Lee WW; Yang YJ; Moon DH; Park SW
    Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1304-11. PubMed ID: 15221289
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Study on molecular imaging and radionuclide therapy of human nasopharyngeal carcinoma cells transfected with baculovirus-mediated sodium/iodine symporter gene.
    Wang J; Liu S; Wang J; Zhang Y; Li B; Cai C; Wang S
    Int J Oncol; 2013 Jul; 43(1):177-84. PubMed ID: 23670584
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Experimental study of nasopharyngeal carcinoma radionuclide imaging and therapy using transferred human sodium/iodide symporter gene.
    Zhong X; Shi C; Gong J; Guo B; Li M; Xu H
    PLoS One; 2015; 10(1):e0117053. PubMed ID: 25615643
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
    Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
    Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy.
    Shen DH; Marsee DK; Schaap J; Yang W; Cho JY; Hinkle G; Nagaraja HN; Kloos RT; Barth RF; Jhiang SM
    Gene Ther; 2004 Jan; 11(2):161-9. PubMed ID: 14712300
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells.
    Haberkorn U; Beuter P; Kübler W; Eskerski H; Eisenhut M; Kinscherf R; Zitzmann S; Strauss LG; Dimitrakopoulou-Strauss A; Altmann A
    J Nucl Med; 2004 May; 45(5):827-33. PubMed ID: 15136633
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer.
    Dwyer RM; Ryan J; Havelin RJ; Morris JC; Miller BW; Liu Z; Flavin R; O'Flatharta C; Foley MJ; Barrett HH; Murphy JM; Barry FP; O'Brien T; Kerin MJ
    Stem Cells; 2011 Jul; 29(7):1149-57. PubMed ID: 21608083
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endogenous expression of the sodium iodide symporter mediates uptake of iodide in murine models of colorectal carcinoma.
    Gaertner FC; Rohde F; Mueller J; Blechert B; Janssen KP; Essler M
    Int J Cancer; 2009 Dec; 125(12):2783-91. PubMed ID: 19569179
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E; Unfer R; Vahanian N; Link C
    Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effective cancer therapy with the alpha-particle emitter [211At]astatine in a mouse model of genetically modified sodium/iodide symporter-expressing tumors.
    Petrich T; Quintanilla-Martinez L; Korkmaz Z; Samson E; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
    Clin Cancer Res; 2006 Feb; 12(4):1342-8. PubMed ID: 16489092
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Radioiodide imaging and treatment of ARO cancer xenograft in a mouse model after expression of human sodium iodide symporter.
    Hsieh YJ; Ke CC; Liu RS; Wang FH; Tang KT; Chi CW; Chen FD; Lee CH
    Anticancer Res; 2007; 27(4B):2515-22. PubMed ID: 17695547
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.
    Knoop K; Schwenk N; Dolp P; Willhauck MJ; Zischek C; Zach C; Hacker M; Göke B; Wagner E; Nelson PJ; Spitzweg C
    Hum Gene Ther; 2013 Mar; 24(3):306-16. PubMed ID: 23402366
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
    Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3).
    Sieger S; Jiang S; Schönsiegel F; Eskerski H; Kübler W; Altmann A; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):748-56. PubMed ID: 12541134
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.
    Grünwald GK; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Göke B; Holm PS; Spitzweg C
    Gene Ther; 2013 Jun; 20(6):625-33. PubMed ID: 23038026
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Noninvasive imaging for monitoring of viable cancer cells using a dual-imaging reporter gene.
    Shin JH; Chung JK; Kang JH; Lee YJ; Kim KI; So Y; Jeong JM; Lee DS; Lee MC
    J Nucl Med; 2004 Dec; 45(12):2109-15. PubMed ID: 15585489
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effective treatment of pancreatic neuroendocrine tumours transfected with the sodium iodide symporter gene by 186Re-perrhenate in mice.
    Riese CG; Seitz S; Schipper ML; Behr TM
    Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1767-73. PubMed ID: 19449003
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Determination of the optimal time for radioiodine therapy in anaplastic thyroid carcinoma using the adenovirus-mediated transfer of sodium iodide symporter gene.
    So Y; Lee YJ; Lee WW; Chung JK
    Oncol Rep; 2013 Apr; 29(4):1666-70. PubMed ID: 23404348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.